The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Bassett, A. S.
* Articles by Weksberg, R.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Bassett, A. S.
* Articles by Weksberg, R.
Related Collections
* Schizophrenia Spectrum Disorders
* Genetics
Am J Psychiatry 160:1580-1586, September 2003
© 2003 American Psychiatric Association


Article

The Schizophrenia Phenotype in 22q11 Deletion Syndrome

Anne S. Bassett, M.D., F.R.C.P.C., Eva W.C. Chow, M.D., F.R.C.P.C., Philip AbdelMalik, B.Sc., Mirona Gheorghiu, B.A., Janice Husted, Ph.D., and Rosanna Weksberg, Ph.D., M.D., F.R.C.P.C.

OBJECTIVE: This study investigated the schizophrenia phenotype in 24 subjects with 22q11 deletion syndrome (22qDS) and schizophrenia (22qDS-schizophrenia), a rare but relatively homogenous genetic subtype of schizophrenia associated with a microdeletion on chromosome 22. Individuals with 22qDS are at genetically high risk for schizophrenia. METHOD: Standard measures of signs, symptoms, and course of schizophrenia were assessed in 16 adults with 22qDS-schizophrenia who did not meet criteria for mental retardation and in 46 adults with schizophrenia without evidence of 22qDS from a community familial sample. RESULTS: There were no significant differences in age at onset, lifetime or cross-sectional core positive and negative schizophrenic symptoms, or global functioning between the two groups of patients with schizophrenia. Patients with 22qDS-schizophrenia had higher excitement subscale scores and less lifetime substance use than the comparison patients with schizophrenia, but no significant differences in anxiety-depression symptom severity were found between the groups. CONCLUSIONS: These findings indicate that the core clinical schizophrenia phenotype would not distinguish individuals with a 22qDS subtype from those with schizophrenia who did not have the 22qDS subtype. The results provide further support for the utility of 22qDS-schizophrenia as a neurodevelopmental model of schizophrenia as well as support for prospective studies of individuals with 22qDS to help identify precursors of schizophrenia.




This article has been cited by other articles:


Home page
J. Med. Genet.Home page
A S Bassett, E W C Chow, J Husted, K A Hodgkinson, E Oechslin, L Harris, and C Silversides
Premature death in adults with 22q11.2 deletion syndrome
J. Med. Genet., May 1, 2009; 46(5): 324 - 330.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
T. R. Kiehl, E. W. C. Chow, D. J. Mikulis, S. R. George, and A. S. Bassett
Neuropathologic Features in Adults with 22q11.2 Deletion Syndrome
Cereb Cortex, January 1, 2009; 19(1): 153 - 164.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. S. Bassett, C. R. Marshall, A. C. Lionel, E. W.C. Chow, and S. W. Scherer
Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome
Hum. Mol. Genet., December 15, 2008; 17(24): 4045 - 4053.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Budel, T. Padukkavidana, B. P. Liu, Z. Feng, F. Hu, S. Johnson, J. Lauren, J. H. Park, A. W. McGee, J. Liao, et al.
Genetic Variants of Nogo-66 Receptor with Possible Association to Schizophrenia Block Myelin Inhibition of Axon Growth
J. Neurosci., December 3, 2008; 28(49): 13161 - 13172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
D. Gothelf, C. Feinstein, T. Thompson, E. Gu, L. Penniman, E. Van Stone, H. Kwon, S. Eliez, and A. L. Reiss
Risk Factors for the Emergence of Psychotic Disorders in Adolescents With 22q11.2 Deletion Syndrome
Am J Psychiatry, April 1, 2007; 164(4): 663 - 669.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
G. Raux, E. Bumsel, B. Hecketsweiler, T. van Amelsvoort, J. Zinkstok, S. Manouvrier-Hanu, C. Fantini, G.-M. M. Breviere, G. Di Rosa, G. Pustorino, et al.
Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome
Hum. Mol. Genet., January 1, 2007; 16(1): 83 - 91.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Paylor, B. Glaser, A. Mupo, P. Ataliotis, C. Spencer, A. Sobotka, C. Sparks, C.-H. Choi, J. Oghalai, S. Curran, et al.
Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: Implications for 22q11 deletion syndrome
PNAS, May 16, 2006; 103(20): 7729 - 7734.
[Abstract] [Full Text] [PDF]


Home page
J Am Acad Psychiatry LawHome page
V. Harris
22q11 Deletion Syndrome and Forensic Research: Can We Go There?
J Am Acad Psychiatry Law, March 1, 2005; 33(1): 106 - 111.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
K. D. BAKER and D. H. SKUSE
Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group
The British Journal of Psychiatry, February 1, 2005; 186(2): 115 - 120.
[Abstract] [Full Text] [PDF]


Home page
JWatch PsychiatryHome page
A Look at Schizophrenia in Patients with 22q11 Deletion Syndrome
Journal Watch Psychiatry, November 5, 2003; 2003(1105): 7 - 7.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org